<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>GBIHealth | wechat-feeds</title><link>http://MzA5Njc0MTAxOQ.favicon.privacyhide.com/favicon.ico</link><description>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 03 Mar 2021 08:13:00 +0800</pubDate><image><url>http://MzA5Njc0MTAxOQ.favicon.privacyhide.com/favicon.ico</url><title>GBIHealth | wechat-feeds</title><link>http://MzA5Njc0MTAxOQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>专题报告 | 第四批带量采购：合同金额过亿品种多索茶碱居首；全部四批集采齐鲁制药中标数最多</title><link>https://mp.weixin.qq.com/s/MJZ8a6N_FBAHubHJjrfhQg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NvwSYjaWjCShjaiaLXGZHZByF8K25hIoua3JdXTDo8AiaSyxaEG320QZj1QqZ390aaLZZQlalV6XpQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药品的生命周期或再次缩短，商业化策略面临重新评估。]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:59 +0800</pubDate></item><item><title>年治疗费最低不过万！国产PD-1医保价格曝光；226个药品注册证书被注销；辉瑞BRAF抑制剂获批临床</title><link>https://mp.weixin.qq.com/s/drc-PmeD0kA7DrNr722VEQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:59 +0800</pubDate></item><item><title>财报解析 | 再鼎医药2020年财报：稳步启动商业化，持续精进研发、拓展业务</title><link>https://mp.weixin.qq.com/s/d6rseIW0NG3ikcBBh7LWNA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Pbxic6yr0r5aKEb0XB6uPapodWW77m6vwLf8l8tF2h9brTxricfvKVlwmbLgmsyPia7IHp56F1MiawLw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>公司2020年全年收入为4,900万美元，与2019年相比增长了276.9%。]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:59 +0800</pubDate></item><item><title>财报解析 | 拜耳2020年财报：集采影响亚太地区业绩，全年下降6.3%</title><link>https://mp.weixin.qq.com/s/P3jgjEhPjUIfjPo4FgAY8w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Pbxic6yr0r5aKEb0XB6uPap4NA4ST6NkJiaeibiaDloPCJmgGiaicjQvVEEn525b8BwXw7mYib0uELhvjyA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>最畅销产品拜唐苹和拜复乐进入第二轮带量采购后，对公司业绩产生了消极影响。]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:09:06 +0800</pubDate></item><item><title>拜耳携手中国罕见病联盟；默沙东1类晚期实体瘤新药获批临床；科济药业递交港交所上市申请</title><link>https://mp.weixin.qq.com/s/Kbi7AAmJ2n-CVmEFGCzeHQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:09:06 +0800</pubDate></item><item><title>财报解析 | 百济神州2020年财报：3产品纳入医保目录，商业化走上正轨</title><link>https://mp.weixin.qq.com/s/m7W1tGvr0sEfbUgyXVjYsA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Pbxic6yr0r5aKEb0XB6uPapodWW77m6vwLf8l8tF2h9brTxricfvKVlwmbLgmsyPia7IHp56F1MiawLw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>全年同比增长约38％！]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:09:06 +0800</pubDate></item><item><title>喜提GPI中国总代理，GBI开拓国际市场准入服务，助力企业实现“出海”自由</title><link>https://mp.weixin.qq.com/s/yUsMF4NZhRsmhW8Xi1p0Ag</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6MUoH0AvyJI7yXWVf4UcpVkaaudw88bu6licDdb6hlj7X2ER7icZJOmcVtzJia6Hiamse4covNic1ArIdQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>助力药企市场准入，我们是专业的，也一直在努力！]]></content:encoded><pubDate>Sun, 28 Feb 2021 22:48:06 +0800</pubDate></item><item><title>第一三共拆分近47亿日元成熟药品；北海康成终止奈拉替尼许可协议；O药生物类似药临床申请获受理</title><link>https://mp.weixin.qq.com/s/7XRtv7TA82m-QNuVBV-ESA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Sun, 28 Feb 2021 22:48:06 +0800</pubDate></item><item><title>DEVINT | 1月117个医疗器械获批，30个进口，1个台湾产品；临床特检服务提供商康圣环球拟港交所IPO</title><link>https://mp.weixin.qq.com/s/td1BiJvsOxPb_whcsfAxzQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6OjYicnPOau4chTfznQSoEN1GAdibdqbhXiaEyaZ2G0VHhfp1hGKmQkMshDzOuaTr7tCj7ibGKG8fBVVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>包含：美敦力程控充电套件和腰骶前路钉板固定系统，罗氏诊断肝素校准品]]></content:encoded><pubDate>Sun, 28 Feb 2021 22:48:06 +0800</pubDate></item><item><title>重磅！阿斯利康中国与君实生物就抗PD-1单抗药物达成授权合作</title><link>https://mp.weixin.qq.com/s/LExte1bQXI6ncbT6B2PbUw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Ob9BSvDPzDWg75ia5HGSoDkM1GsFPVvtPBiae4SESA4iaJWJFLRPpwJLXpDBnZgyG5rZ9ffMbTtz3ZQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>强强联手深化本土合作，创新药物惠及广大患者]]></content:encoded><pubDate>Sun, 28 Feb 2021 19:22:04 +0800</pubDate></item><item><title>成功出圈！22位医药女BOSS上榜福布斯2021中国杰出商界女性百强榜</title><link>https://mp.weixin.qq.com/s/0XVb452SvbP_IL4w6iLADA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6OFEkj7uibSPACYcpOebiaVmI4FTBUnS2UXW7wBnYRKfrT8Qb3gnTgEBhup6PGqWVpBLPiab0arL0shA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>在咱药圈，向来女性能顶起的远不止半边天​。]]></content:encoded><pubDate>Thu, 25 Feb 2021 17:31:21 +0800</pubDate></item><item><title>阿斯利康红斑狼疮创新疗法获批临床；德琪医药ATG-010上市申请获优先审评；中国生物制药启动科创板上市辅导</title><link>https://mp.weixin.qq.com/s/3Tqj2qKnrFEArqdpWcLdww</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Thu, 25 Feb 2021 17:31:21 +0800</pubDate></item><item><title>DEVINT | 江西省发布药品医用耗材挂网采购工作实施方案</title><link>https://mp.weixin.qq.com/s/SA40SZWRRooGUY3Um4IAuw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6OjYicnPOau4chTfznQSoEN1GAdibdqbhXiaEyaZ2G0VHhfp1hGKmQkMshDzOuaTr7tCj7ibGKG8fBVVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>价格方面，《方案》要求实行“红黄绿”线价格提示。]]></content:encoded><pubDate>Thu, 25 Feb 2021 17:31:21 +0800</pubDate></item><item><title>专题报告 | 2020年获批新药：化药数量国产首次反超进口，生物药进口为主流</title><link>https://mp.weixin.qq.com/s/Ygy52Z36rwKrWmXgrAsjjw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6PC88ictQHoiaEMjowD7h8f6gWDTPebZ0zG34fCJevker4mw9u86R2S0KyCqEPFVwB7wD75seLkBpOg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2020年共批准上市55个西药，与2019年57个西药基本持平。]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:23:15 +0800</pubDate></item><item><title>5.2亿美元！中国生物达成纤维化创新药交易；BI公司GLP-1/胰高血糖素双激动剂获批临床；康希诺新冠疫苗附条件上市申请获受理</title><link>https://mp.weixin.qq.com/s/1x6HNj6ZprpQ7579lmbYyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:23:15 +0800</pubDate></item><item><title>DEVINT | Fluidigm合作普罗亭，向中国临床实验室推广CyTOF技术</title><link>https://mp.weixin.qq.com/s/AbhLDavFJKRQF-trir-5Vw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6OjYicnPOau4chTfznQSoEN1GAdibdqbhXiaEyaZ2G0VHhfp1hGKmQkMshDzOuaTr7tCj7ibGKG8fBVVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>双方将向国家药监局提交CyTOF平台的临床诊断注册申报]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:23:15 +0800</pubDate></item><item><title>生物类似药带量采购逼近，GBI生物药监测服务，助您“眼观六路”提早应对！</title><link>https://mp.weixin.qq.com/s/eE5YvGn6bJVDjEPUdyhiUg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6PC88ictQHoiaEMjowD7h8f6gqTBib1mdfcIQTUCVE8icSNOkeDuetVicich2b5p8uQEOr4sLNoJ1mRA7kw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>此次《指导原则》的发布进一步释放信号：生物类似药带量采购真要来了！]]></content:encoded><pubDate>Tue, 23 Feb 2021 18:49:50 +0800</pubDate></item><item><title>阿斯利康撤回Imfinzi膀胱癌美国上市资格；上药PD-1单抗获批Ⅲ期临床；康方生物PD-1/CTLA-4双抗获FDA孤儿药认定</title><link>https://mp.weixin.qq.com/s/TypNWXbRgHGu8BKNr00neQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Tue, 23 Feb 2021 18:49:50 +0800</pubDate></item><item><title>DEVINT | 工信部发布《医疗装备产业发展规划（2021-2025年）》（征求意见稿）</title><link>https://mp.weixin.qq.com/s/V8ff-elFFx236Skx-Xxfxw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6OjYicnPOau4chTfznQSoEN1GAdibdqbhXiaEyaZ2G0VHhfp1hGKmQkMshDzOuaTr7tCj7ibGKG8fBVVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月11日前面向社会公开征求意见]]></content:encoded><pubDate>Tue, 23 Feb 2021 18:49:50 +0800</pubDate></item><item><title>独家访谈 | 君圣泰CEO刘利平：带领治疗慢性肝病药物登上国际舞台</title><link>https://mp.weixin.qq.com/s/mJG66NORgKAzzKl2bpdxPg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NtwmIx6qkfX0ThLvguAOHLkRjelEmWzVZRaiaptn6PErHAxibyKUB29LgOeDmm3nCEy1f6RPD95r4g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>刘博士对君圣泰旗下重磅首创新药HTD1801进行了详细介绍]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:33:15 +0800</pubDate></item></channel></rss>